Mudit Mishra Selected Research

MDCO-216

1/2020	Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension.
3/2019	Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice.
11/2018	Successful treatment of established heart failure in mice with recombinant HDL (Milano).
10/2018	Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mudit Mishra Research Topics

Disease

7	Heart Failure 11/2021 - 09/2017
7	Fibrosis (Cirrhosis) 12/2020 - 01/2017
4	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2017
4	Cardiomegaly (Heart Hypertrophy) 12/2020 - 09/2017
2	Diabetic Cardiomyopathies 01/2022 - 03/2019
2	Reperfusion Injury 11/2021 - 01/2020
2	Myocardial Infarction 11/2021 - 01/2020
2	Hypercholesterolemia 05/2019 - 01/2019
2	Pulmonary Edema 03/2019 - 01/2017
1	Hyperglycemia 01/2022
1	Infarction (Infarctions) 11/2021
1	Primary Graft Dysfunction 01/2020
1	Hypertrophy 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Cardiac Edema 01/2020
1	Microvascular Rarefaction 01/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 05/2019
1	Heart Diseases (Heart Disease) 01/2018
1	Hypotension (Low Blood Pressure) 01/2018
1	Weight Gain 01/2017
1	Obesity 01/2017
1	Insulin Resistance 01/2017

Drug/Important Bio-Agent (IBA)

4	MDCO-216IBA 01/2020 - 10/2018
3	CholesterolIBA 05/2019 - 11/2017
2	EnzymesIBA 01/2022 - 11/2021
2	AntioxidantsIBA 01/2022 - 11/2021
2	HDL LipoproteinsIBA 12/2020 - 09/2017
2	LDL Receptors (LDL Receptor)IBA 05/2019 - 01/2019
2	HDL CholesterolIBA 01/2019 - 09/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 11/2021
1	ThioredoxinsIBA 11/2021
1	Heme Oxygenase-1IBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	apolipoprotein A-I MilanoIBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	CytokinesIBA 01/2020
1	Apolipoproteins AIBA 01/2020
1	Sucrose (Saccharose)IBA 05/2019
1	SugarsIBA 03/2019
1	BuffersIBA 11/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2017
1	Coconut OilIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017

Therapy/Procedure

2	Therapeutics 11/2021 - 12/2020
1	Heart Transplantation (Grafting, Heart) 01/2020